Cala Health is a bioelectronic medicine company founded in 2014 and headquartered in Silicon Valley, California. It originated as a spinout from Stanford Biodesign. The company specializes in developing non-invasive wearable therapies that use peripheral nerve stimulation to treat chronic diseases, operating at the intersection of neuroscience, engineering, and neuromodulation.
The company's primary commercial product is the Cala kIQ system. This prescription wrist-worn device is FDA-cleared to treat action hand tremor in adults with essential tremor and Parkinson's disease. It was the first FDA-cleared non-invasive prescription therapy for this condition. The device works by applying Transcutaneous Afferent Patterned Stimulation (TAPS).
Cala Health's therapeutic focus spans several medical specialties, including neurology, cardiology, and psychiatry, with a broader goal of transforming the standard of care for chronic disease management. The company reports that its technology has empowered thousands of patients.
